Literature DB >> 14624392

Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.

Bethany L Niell1, Jeffrey C Long, Gad Rennert, Stephen B Gruber.   

Abstract

The adenomatous polyposis coli (APC) I1307K allele is found in 6% of the Ashkenazi Jewish population and in 1%-2% of Sephardi Jews; it confers a relative risk of 1.5-2.0 for colorectal cancer (CRC) on all carriers. Within the Ashkenazim, the existence of numerous high-prevalence mutations, including I1307K, has sparked controversy over whether genetic drift or selection is the underlying cause. For the present population-based case-control study of CRC in Israel, we tested whether selection has operated at I1307K. We also estimated the age of the I1307K allele, to understand its origin in the context of the Jewish diasporas and subsequent founder events. We genotyped 83 matched pairs, in which one or both members of the pair carried I1307K, at three microsatellites and two SNPs. Haplotypes were statistically constructed using PHASE software. Single-marker age estimates for I1307K were calculated using the approach described by Risch et al. A common progenitor haplotype spanned across APC I1307K from the centromeric marker D5S135 to the telomeric marker D5S346 and was observed in individuals of Ashkenazi, Sephardi, and Arab descent. The ancestor of modern I1307K alleles existed 87.9-118 generations ago ( approximately 2,200-2,950 years ago). This age estimate indicates that I1307K existed at about the time of the beginning of the Jewish diaspora, explaining its presence in non-Ashkenazi populations. Our data do not indicate that selection operated at I1307K (D5S346, P=.114; D5S135, P=.373), providing compelling evidence that the high frequency of disease-susceptibility alleles in the Ashkenazim is due to genetic drift, not selection. This research underscores the importance of the migratory patterns of ancestral populations in the ethnic and geographic distribution of APC I1307K.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624392      PMCID: PMC1180391          DOI: 10.1086/379926

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.

Authors:  D B Goldstein; D E Reich; N Bradman; S Usher; U Seligsohn; H Peretz
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  The use of intraallelic variability for testing neutrality and estimating population growth rate.

Authors:  M Slatkin; G Bertorelle
Journal:  Genetics       Date:  2001-06       Impact factor: 4.562

3.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

4.  Genealogical inference from microsatellite data.

Authors:  I J Wilson; D J Balding
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

5.  Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.

Authors:  Y Nakamura; M Lathrop; M Leppert; M Dobbs; J Wasmuth; E Wolff; M Carlson; E Fujimoto; K Krapcho; T Sears
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

6.  Assay for Detecting the I1307K Susceptibility Allele within the Adenomatous Polyposis ColiGene.

Authors:  S B Gruber
Journal:  Methods Mol Med       Date:  2001

7.  Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.

Authors:  L Drucker; O Shpilberg; A Neumann; J Shapira; R Stackievicz; Y Beyth; S Yarkoni
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

8.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

Authors:  S J Laken; G M Petersen; S B Gruber; C Oddoux; H Ostrer; F M Giardiello; S R Hamilton; H Hampel; A Markowitz; D Klimstra; S Jhanwar; S Winawer; K Offit; M C Luce; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

9.  Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians.

Authors:  M Labuda; D Labuda; M Korab-Laskowska; D E Cole; E Zietkiewicz; J Weissenbach; E Popowska; E Pronicka; A W Root; F H Glorieux
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

10.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors:  S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

View more
  25 in total

1.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

2.  An ancient autosomal haplotype bearing a rare achromatopsia-causing founder mutation is shared among Arab Muslims and Oriental Jews.

Authors:  Lina Zelinger; Alex Greenberg; Susanne Kohl; Eyal Banin; Dror Sharon
Journal:  Hum Genet       Date:  2010-06-13       Impact factor: 4.132

3.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

4.  Colonic Adenomas Do Not Cosegregate with the I1307K APC Missense Mutation in an Israeli Non-Ashkenazi Family.

Authors:  Herma H Fidder; Arie Figer; Jamal Zidan; Shimon Bar Meir; Eitan Friedman
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

5.  Double frameshift mutations in APC and MSH2 in the same individual.

Authors:  Claudio Soravia; Celia D DeLozier; Zurana Dobbie; Claudine Rey Berthod; Eviano Arrigoni; Marie-Anne Bründler; Jean-Louis Blouin; William D Foulkes; Pierre Hutter
Journal:  Int J Colorectal Dis       Date:  2005-09       Impact factor: 2.571

6.  Tay-Sachs disease preconception screening in Australia: self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421 + 1G > C mutation in individuals with South African heritage.

Authors:  Raelia Lew; Leslie Burnett; Anné Proos
Journal:  J Community Genet       Date:  2011-07-15

7.  How old is this mutation? - a study of three Ashkenazi Jewish founder mutations.

Authors:  Celia M T Greenwood; Shuying Sun; Justin Veenstra; Nancy Hamel; Bethany Niell; Stephen Gruber; William D Foulkes
Journal:  BMC Genet       Date:  2010-05-14       Impact factor: 2.797

8.  Fine-scale detection of population-specific linkage disequilibrium using haplotype entropy in the human genome.

Authors:  Hideaki Mizuno; Gurinder Atwal; Haijian Wang; Arnold J Levine; Alexei Vazquez
Journal:  BMC Genet       Date:  2010-04-23       Impact factor: 2.797

9.  Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families.

Authors:  M Daniele Fallin; Virginia K Lasseter; Paula S Wolyniec; John A McGrath; Gerald Nestadt; David Valle; Kung-Yee Liang; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

10.  American founder mutation for attenuated familial adenomatous polyposis.

Authors:  Deborah W Neklason; Jeffery Stevens; Kenneth M Boucher; Richard A Kerber; Nori Matsunami; Jahn Barlow; Geraldine Mineau; Mark F Leppert; Randall W Burt
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12-11       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.